Beuers U - Search Results

1

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.

Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G. Beuers U, et al. Hepatology. 1992 Sep;16(3):707-14. doi: 10.1002/hep.1840160315. Hepatology. 1992. PMID: 1505913 Clinical Trial.

2

Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis.

Beuers U, Spengler U, Sackmann M, Paumgartner G, Sauerbruch T. Beuers U, et al. J Hepatol. 1992 May;15(1-2):140-3. doi: 10.1016/0168-8278(92)90026-l. J Hepatol. 1992. PMID: 1506631

3

Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.

Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Beuers U, et al. Hepatology. 1992 Apr;15(4):603-8. doi: 10.1002/hep.1840150409. Hepatology. 1992. PMID: 1551637

4

Hepatitis after chronic abuse of senna.

Beuers U, Spengler U, Pape GR. Beuers U, et al. Lancet. 1991 Feb 9;337(8737):372-3. doi: 10.1016/0140-6736(91)91012-j. Lancet. 1991. PMID: 1671276 No abstract available.

5

Deoxycholic acid is not reconverted to cholic acid in humans--a study by isotope ratio mass spectrometry.

Fischer S, Beuers U, Berr F, Paumgartner G. Fischer S, et al. Among authors: beuers u. Clin Chim Acta. 1991 Dec 16;203(2-3):269-73. doi: 10.1016/0009-8981(91)90299-r. Clin Chim Acta. 1991. PMID: 1777986 No abstract available.

6

Klinefelter's syndrome and liver adenoma.

Beuers U, Richter WO, Ritter MM, Wiebecke B, Schwandt P. Beuers U, et al. J Clin Gastroenterol. 1991 Apr;13(2):214-6. doi: 10.1097/00004836-199104000-00020. J Clin Gastroenterol. 1991. PMID: 1851773

7

Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.

Beuers U, Fischer S, Spengler U, Paumgartner G. Beuers U, et al. J Hepatol. 1991 Jul;13(1):97-103. doi: 10.1016/0168-8278(91)90870-h. J Hepatol. 1991. PMID: 1918882

8

Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.

Beuers U, Ritter MM, Richter WO, Paumgartner G. Beuers U, et al. Arch Intern Med. 1990 Jul;150(7):1542. Arch Intern Med. 1990. PMID: 2142412 No abstract available.

9

Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine.

Beuers U, Thiel M, Bardenheuer H, Paumgartner G. Beuers U, et al. Biochem Biophys Res Commun. 1990 Sep 28;171(3):1115-21. doi: 10.1016/0006-291x(90)90800-3. Biochem Biophys Res Commun. 1990. PMID: 2222431

10

[Chronic increased cholestasis parameters and sonographic echogenic round liver lesions in a clinically healthy male].

Spengler U, Beuers U, Gokel W, Pape GR, Paumgartner G. Spengler U, et al. Among authors: beuers u. Internist (Berl). 1989 Apr;30(4):265-8. Internist (Berl). 1989. PMID: 2661467 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters